BIOMERICA INC (BMRA)

US09061H3075 - Common Stock

0.2789  +0.01 (+4.85%)

BIOMERICA INC

NASDAQ:BMRA (12/20/2024, 8:00:01 PM)

0.2789

+0.01 (+4.85%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustryHealth Care Equipment
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-11.76%
Sales Q2Q%5.67%
CRS7.67
6 Month-37.79%
Overview
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)01-14 2025-01-14
Ins Owners7.22%
Inst Owners17.12%
Market Cap4.69M
Shares16.82M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts85.71
Short Float %9.13%
Short Ratio1.31
IPO03-17 1980-03-17
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BMRA Daily chart

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 63 full-time employees. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. The company is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Company Info

BIOMERICA INC

17571 Von Karman Avenue

Irvine CALIFORNIA 92614

P: 19493792875

CEO: Zackary S. Irani

Employees: 63

Website: https://biomerica.com/

BMRA News

ChartMill News Image16 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Which stocks are experiencing notable movement on Friday?

ChartMill News Image21 days ago - ChartmillTop movers in Monday's pre-market session

Which stocks are moving before the opening bell on Monday?

News Imagea month ago - Biomerica, Inc.Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis

New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn’s Disease ($2.5 billion+), and...

News Image2 months ago - Biomerica, Inc.Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced...

News Image2 months ago - Biomerica, Inc.Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Patients experiencing bloating and gastrointestinal discomfort can now order inFoods® IBS directly from www.infoodsIBS.com without needing to visit a...

News Image2 months ago - Biomerica, Inc.Biomerica Reports First Quarter Fiscal 2025 Financial Results

Total Revenue Increases 6% Over Same Period Last Year Cost-Saving Measures Now Implemented, Expected to Reduce Annual Expenses by 16% to...

BMRA Twits

Here you can normally see the latest stock twits on BMRA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example